PUBLIC CONTRACT · 2024
Q1/1074/2024 - Eritropoetina alfa 30000 u.i./0.75ML sol inj.iv/sc / eritropoetina beta 30.000UI/0.6 ml sol inj IV/sc
- Contract value
- €48,600.00
- Signed on
- 26 March 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10842715PUBLISHED SUBJECT
Q1/1074/2024 - ERITROPOETINA ALFA 30000 U.I./0.75ML SOL INJ.IV/SC / ERITROPOETINA BETA 30.000UI/0.6 ML SOL INJ IV/SC
Parties involved
- Place of performance
- Portugal, Leiria, Leiria
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
Values and timeline
- Contract price
- €48,600.00
- Procedure base price
- €48,600.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 30 July 2024
- Award date
- 26 March 2024
- Signing date
- 26 March 2024
- Performance period
- 184 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 307/2023 - Estimulantes da eritropoiese
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7152109
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.